In holistic care, the information related to the whole person is integrated into the patient’s evaluation and treatment, beyond just the focus on the disease. Even more complex schools of holistic thought promote the idea that humans are constantly sharing their space with a multitude of other organisms that mutually impact the environment that influences our well being. If we can understand these factors, and their interplay, we could shift from the reliance upon treatment care only towards preventative care, which is one of the central concepts of holistic care.
One recent disruptive technology that currently allows a unique whole analysis of personal biology is genome sequencing. This technology not only allows for the study of the entire DNA code of a person, but also for the complex community of microorganisms that coexist within an individual, the pathogens that infect us, and their interplay with the other animals in our environment.
While we are still deciphering the intricacies that such novel complex information is providing us, personal whole genome sequencing is starting to usher in the promise of preventative medicine. The big three items that personal access to one’s own genome offers are:
Predisposition to pathogenic conditions for which intervention or treatment is available
Information on medication dosing, efficacy or toxicity
Information on pathogenic conditions that could develop in offspring if both parents are
carriers of the same mutations (even while the parents are completely unaffected)
Having access to such information prior to disease development allows the focus to be shifted to either preventative care to ensure the outcome does not manifest, or to screening for those conditions to ensure the earliest possible management for each condition as it arises. Information regarding personalized drug use can reduce the trial-and-error approach and find the medication that best matches the condition to be treated in each specific individual.
The impact of genome sequencing is not only investigated in healthy individuals, however. The most common beneficiaries of these technologies are cancer patients, as well as individuals with undiagnosed diseases that cannot be solved with the current standard medical approaches. In both instances, the goal of the DNA test is to help elucidate the molecular footprint that contributed to the disease development, in the hope of attaining a precise treatment approach that is specific to the diagnosed problem.
Merogenomics Inc. is a consulting company that provides private access to genome sequencing and related technologies, specializing in cancer profiling, prenatal screening, undiagnosed diseases, and preventative screening. We help our clients access a variety of commercially available DNA sequencing tests, and help guide each person through this complex but fascinating process, providing background education to both the client and the doctor overseeing the medical interpretation of the genome sequencing results.
We are seeking to promote genome sequencing in health care practices, and offer a generous $500 referral fee for clients. Please contact Merogenomics for details. The use of genome sequencing complements the holistic care approach, promoting values on personalized, preventive, and wellness oriented patient care.
This document is a property of Merogenomics Inc. © 2017 All rights reserved